A positive tuberculosis (TB) skin test can look different depending on your risk factors. Learn risk factors to consider and what a positive test may look like.

Although tuberculosis is uncommon in the U.S., ... had planned to utilize a secondary patent to extend their control of it until the end of 2027, advocates say. ...

What is TB? Tuberculosis, also known as TB, is a bacterial infection that primarily affects a person's lungs. Its symptoms vary widely depending on how the slow-growing mycobacterium that causes ...

Our lungs are amazing, quietly doing their thing to keep us breathing and alive. But when they are compromised by disease, ...

Now, the group is turning attention to Otsuka’s TB drug delamanid and its secondary patents, it said in a recent statement. Johnson & Johnson Sirturo bedaquiline Tuberculosis Pharma.

Subgroup analyses based on HIV infection status found a strong protective effect of INH against TB among HIV-negative children (RR = 0.55, 95% CI 0.40, 0.75 p = 0.001), but no evidence of an ...

Treating latent TB will prevent them from having active or secondary TB. Treatment for latent TB is quite different from that of active TB. So, you must be distinctively tested and detected.

Tuberculosis outbreaks in Pond Inlet and Pangnirtung have been resolved, according to Nunavut's Department of Health on July ...

T he patent on the tuberculosis drug bedaquiline expires today (July 18). But while its manufacturer, Johnson & Johnson, intends to use secondary patents to extend its exclusive right to sell the ...

TB is bad enough, but multidrug-resistant TB is worse. A drug crucial to treatment must be made more affordable and widely available by Johnson & Johnson.

The organization, also known as Médecins Sans Frontières (MSF), is calling on Johnson & Johnson to publicly commit to not enforcing secondary patents on tuberculosis med Sirturo in countries ...

In two of the trials, INH prophylaxis was administered for a duration of less than six months, while in the other six it was administered for six months or longer. The duration of follow-up among ...